Abstract
In 2014, the Foundation for the National Institutes of Health (FNIH) Sarcopenia Project defined individuals with sarcopenia as having a clinically relevant low muscle strength (weakness) and low level of lean muscle mass (1) (2) (3) (4) (5) (6) . The Asian Working Group for Sarcopenia (AWGS) also developed criteria for the diagnosis of sarcopenia in the Asian population. The AWGS recommended that sarcopenia be defined as low muscle mass plus low muscle strength and/or low physical performance (7) . However, research on sarcopenia in older Korean people, especially women, is impeded by the fact that the current generation tends to be taller than previous generations, while their appendicular skeletal muscle mass (ASM), when adjusted for the height squared (ASM Ht 2) , is lower (8) . Because of this generational cohort effect, earlier studies on sarcopenia in older Korean people that used existing epidemiologic cut-off points did not show consistent results. Therefore, establishing specific and clinically relevant criteria for the diagnosis of sarcopenia would be extremely useful for those researching sarcopenia in older Korean people.
Furthermore, the FNIH sarcopenia criteria may be inappropriate for older Korean people because 90.5% of the men and 89.9% of the women in the FNIH sarcopenia project were Caucasian (1). The differences between Asian and Caucasian populations have been documented. For example, in one study conducted in Taiwan, grip strength (GS) values in Asians were significantly lower (by 25% in men and 27% in women) than Caucasians, and the most influential factor was palm length (7, 9) . Accordingly, if the FNIH criteria are used for the diagnosis of sarcopenia in older Asians, the prevalence of sarcopenia will be overestimated. In addition, two of the diagnostic indicators that are used in the FNIH operational criteria for sarcopenia-the GS and the ASM adjusted for body mass index (BMI) (ASM BMI )-correlate positively with height in older Korean people, and the ASM Ht 2), a diagnostic criterion of the AWGS, is also positively correlated with height. Consequently, short, older Korean people are more likely to be included in weak or low ASM groups than taller people (Supplementary Figures  1-2) . Therefore, new cut-off points for the diagnosis of sarcopenia in older Korean people are needed.
We aimed to identify height-adjusted GS and ASM cut-off points that would be clinically relevant in older Korean population, and we compared the predictive validity of our criteria with those of the operational definitions used by the FNIH Sarcopenia Project and the AWGS.
Methods

Study Population
The study population consisted of 916 older Koreans (429 men and 487 women), who were 65 years of age or older, and were selected to participate in the survey. The study population was recruited from the Bitgoeul Senior Health Town, a retirement community for senior citizens located in Gwangju, Korea. We explained the purpose of the study to the residents, and signed consent forms were obtained from the participants. Between February 1, 2015 and August 30, 2015, two trained nurses who were in attendance at the Bitgoeul Senior Health Town during working hours helped participants to fill out the questionnaire and performed physical measurements under the supervision of a family physician. Before the study was initiated, the protocol was approved by the Chonnam National University Hwasun Hospital Institutional Review Board (IRB).
Measurement of Usual Gait Speed, GS, and ASM
The study participants were asked to walk 5.5 meters at a comfortable walking speed. The time taken to walk 4 meters, excluding the 0.75 m at the start and at the end of the walk, was measured twice, and the shorter time was selected. The GS was measured using a dynamometer (Hand Grip Meter No. 6103, Tanita, Tokyo, Japan). Each participant was asked to grip the dynamometer twice with the dominant arm in a lowered, straight position, and the higher value was used in the analysis. To measure body composition, direct segmental multifrequency bioelectrical impedance analysis (BIA) (InBody 720, Biospace, Seoul, Korea) was used. The ASM was defined as the sum of the skeletal muscle masses of the upper and lower extremities.
FNIH and AWGS Criteria
The criteria developed by the FNIH Sarcopenia Project were published in 2014. According to the FNIH definition, weakness and low lean muscle mass, that is, low grip strength + low ASM divided by body size (ASM BMI ), are indicators of sarcopenia. Men with a grip strength < 26 kg and women with a grip strength < 16 kg were defined as having weakness. Men with an ASM BMI < 0.789 and women with an ASM BMI < 0.512 were classified as having low lean muscle mass. The cut-off point for weakness is based on the prediction of a slow gait speed (< 0.8 m/s); prediction of weakness was used for low lean muscle mass (1) (2) (3) (4) (5) (6) .
The AWGS criteria were developed for the diagnosis of sarcopenia in the Asian population. The AWGS recommended that sarcopenia be defined as low muscle mass plus low muscle strength and/ or low physical performance. They also suggested cut-off points for muscle mass (7.0 kg/m 2 for men and 5.4 kg/m 2 for women), handgrip strength (< 26 kg for men and < 18 kg for women), and usual gait speed (< 0.8 m/s) (7).
Korean Frailty Index (KFI)
To assess the predictive validity of the cut-off points derived from this study, and to compare the estimated prevalence and predictive validity with those for other operational definitions of sarcopenia, the KFI was used as an outcome variable. Developed by a functional assessment committee for the elderly in Korea in 2010, the KFI comprises 8 criteria (hospital admission, self-assessed health status, polypharmacy, weight loss, depressed mood, incontinence, visual or auditory problems, and the timed up-and-go test [TUG] ), and the score ranges from 0 to 8. Participants with scores of 0 to 2, 3 to 5, and over 5 are classified as "robust," "pre-frail," and "frail," respectively. In this study, two different groups were defined: a "robust" group (score 0-2) and a "pre-frail or frail" group (score [3] [4] [5] [6] [7] [8] , and the results were analyzed (10) (Supplementary Appendix).
Other Covariates
The baseline characteristics of the study participants consisted of age, height, weight, household income level, education level, comorbidity, depression, and cognitive function. Comorbidity included myocardial infarction, angina pectoris, chronic obstructive pulmonary disease, diabetes, osteoarthritis, chronic renal failure, hypertension, congestive heart failure, peripheral artery disease, and cancer. Comorbidity was assessed according to self-reported responses to questions regarding whether one of these conditions had ever been diagnosed in the participants by a doctor. Cognitive function and depressive symptoms were assessed according to the Korean Dementia Screening Questionnaire-Cognition (KDSQ-C) (11) and the Korean version of the Geriatric Depression Scale-Short Form (SGDS-K) (12) , respectively. For this analysis, variables were selected from other studies that are associated with frailty in the elderly (13, 14) .
Statistical Analysis
The main aim of this study was to determine the height-adjusted GS and ASM cut-off points that were best able to reflect a slow usual gait speed and low GS, respectively. To do so, the height-adjusted residual GS (GS re ) and residual ASM (ASM re ) values were calculated by regression analysis using the residual method (15). The GS re and ASM re were obtained by reanalyzing the data from the Survey Before the main statistical analysis, the raw data were divided according to sex to prevent a possible gender effect. We used conditional inference tree (Ctree) analysis to determine height-adjusted GS and ASM cut-off points. The Ctree is a non-parametric classification involving the use of tree-structured regression models in accordance with a well-established theory of conditional inference (16) .
The first part of the main analysis involved the determination of GS cut-off points that would best explain a slow usual gait speed. Gait speed was used as a continuous, dependent variable, whereas GS re was used as an independent variable. For the Ctree analysis, the first branch cut-off point was identified, and was defined as the optimal cut-off point for GS.
The second part involved the determination of the ASM cutoff point that would best reflect a low GS. GS re was used as a continuous, dependent variable, and ASM re served as an independent variable. On Ctree analysis, the first branch cut-off point was defined as the optimal cut-off point for ASM.
In the last part of the main analysis, the participants were divided into a "weak" group and a "low ASM" group, using the cut-off points derived from the Ctree analyses. Participants were classified into the following three groups: not weak ("not weak" group), weak due to a low ASM ("sarcopenia" group), and weak due to other causes ("other weak" group). To compare the predictive validity of these cut-off points with those of the FNIH and the AWGS, univariate and multivariate logistic regression analyses were conducted using the KFI as an outcome variable. In addition, the receiver operating characteristic (ROC) curves were analyzed, followed by the performance of pairwise comparisons of the ROC curves to identify statistically significant differences among the 3 criteria. The logistic regression and ROC curve analyses, for which the KFI was the outcome variable, were used to determine whether each sarcopenia criterion could predict the "not robust" (pre-frail or frail) subjects.
The cut-off value for statistical significance was p < .05. The Ctree analysis was performed using the party package (version 1.0-23) of R software version 3.1.3 (R Core Team, Vienna, Austria); cross-validation was conducted to develop the best-performing cut-off points and to prevent overfitting (16) . ROC curve analysis was conducted using MedCalc version 15.11 (MedCalc Software, Ostend, Belgium).
Results
The mean ages of the men and women in the study were 73 years and 71 years, respectively ( Table 1 Taller men and women had greater GSs and steeper slopes for GS re values. The mean GS re was 0.264 in men and 0.159 in women (Table 1) . In the Ctree model, the first branch was divided into GS re ≤ 0.25 for men and GS re ≤ 0.17 for women. Participants whose GS re was lower than these initial cut-off points were defined as the "weak" group ( Figure 1) . The prevalence of weakness based on the GS re values was 53.6% in men and 50.3% in women (Supplementary Table 1 (Table 1 ). In the Ctree model, the first branch was divided into ASM re ≤ 1.29 for men and ASM re ≤ 0.69 for women whose ASM re was lower than these initial cut-off points, and these participants were defined as the "low ASM" group ( Figure 1 ). The prevalence of weakness as defined by ASM re was 57.8% in men and 47.0% in women (Supplementary Table 1 ).
The proportions of participants with results below the cutoff points for each indicator, separated by height, are presented in Supplementary Table 1 . Accordingly, all of the participants were classified into the "sarcopenia" group, the "other weak" group, and the "not weak" group. Based on the proposed Korean criteria, sarcopenia was diagnosed in 38.7% of men and 30.0% of women. Based on the FNIH criteria, the overall incidence of sarcopenia in men and women was 8.9% and 5.1%, respectively; the corresponding proportions based on AWGS criteria were 11.7% and 9.0%, respectively. The sarcopenia proportions by height quartile differed among the three types of operational criteria for the diagnosis of sarcopenia (Figure 2) .
Based on the KFI, the pre-frail or frail group included 66 men (15.4%) and 106 women (21.8%) (Supplementary Appendix). Univariate and multivariate logistic regression analyses for frailty were conducted to compare the predictive validity of the cut-off points defined by the Korean sarcopenia criteria with the predictive validities of the FNIH and AWGS criteria ( Table 2, Supplementary  Tables 2-4 ). The "not robust" (pre-frail or frail) status defined by the KFI was the outcome variable. The multivariate logistic regression analysis, for which the Korean sarcopenia criteria were used, showed odds ratios (ORs) for men in the "sarcopenia" group and in the "other weak" group for pre-frail or frail of 3.23 (95% confidence interval [CI] 1.33-7.83) and 2.18 (95% CI 1.02-4.66), respectively. The corresponding OR values for women were 1.74 (95% CI 0.91-3.35) and 1.72 (95% CI 0.95-3.13) (Supplementary Table 2 ). In multivariate logistic regression analysis using the FNIH criteria, the men in the "sarcopenia" group and the "other weak" group had OR values for pre-frail or frail of 2.00 (95% CI 0.76-5.05) and 1.37 (95% CI 0.62-3.06), respectively. The OR values for women were 1.47 (95% CI 0.53-4.11) and 1.56 (95% CI 0.81-3.04), respectively (Supplementary Table 3 ). In multivariate logistic regression analysis using the AWGS criteria, the men in the "sarcopenia" group and the "other weak" group showed OR values for pre-frail or frail of 2.72 (95% CI 1.03-7.20) and 3.11 (95% CI 1.50-6.45), respectively. The OR values for women were 3.65 (95% CI 1.59-8.38) and 1.62 (95% CI 0.91-2.89), respectively (Supplementary Table 4) .
ROC curve analysis was conducted, and the unadjusted area under the curve (AUC) for each criterion was obtained to compare the predictive validities of the three different criteria (Table 2, Figure 3 ). For the men, there were no statistically significance differences based on the three types of diagnostic criteria; for the women, the Korean sarcopenia and the AWGS criteria showed no significant differences between the groups, but significant differences were present based on the FNIH criteria.
Discussion
This study aimed to determine clinically relevant cut-off points for the diagnosis of sarcopenia in older Korean people. Our proposed cut-off points using GS re were 0.25 for men and 0.17 for women, while the proposed cut-off points using ASM re were 1.29 for men and 0.69 for women; these cut-off points were equally able to predict frailty, which is less influenced by differences in height than the other two sarcopenia criteria.
Until now, AWGS and FNIH criteria have been commonly used to diagnose sarcopenia in Korean old people. However, parameters such as maximal GS, GS BMI , ASM, ASM Ht 2, and ASM BMI (Supplementary Figure 1-2) have a positive correlation with height, making the diagnosis of sarcopenia in tall patients extremely difficult (Figure 2 ). In particular, the FNIH criteria were greatly influenced by height, as the difference in mean height between the sarcopenia group and the robust group was almost 10 cm (17) . Therefore, we suggested new height-adjusted GS and ASM cut-off points for the diagnosis of sarcopenia in older Korean people.
As more precise measures of GS and ASM were needed, the height-adjusted residual method, which is a modified version of the residual method proposed by Newman, was used (15). The GS re and ASM re were used as indicators to identify weak individuals and those with low ASM values, respectively. However, the number of subjects in this study (n = 916) may not be large enough to calculate values for GS re and ASM re , and may not completely represent the elderly population of Korea. Therefore, the authors reanalyzed the data obtained from the Survey on Health and Welfare Status of the Elderly 2008 (3,609 men and 4,802 women) and the KNHANES IV and V (1,754 men and 2,385 women). The Elderly Survey and KNHANES are nationally representative large-scale surveys of Korean people conducted every 3 years by the Korean Ministry of Health and Welfare and the data from these surveys are used to provide accurate information for health and welfare policies, programs, and research. For the linear regression analysis that was used to calculate the height-adjusted residual values, weight, BMI, and fat mass were excluded to eliminate the influence of obesity. Using these values of GS re and ASM re , we conducted Ctree analysis and identified new cut-off points for GS re (men: 0.25, women: 0.17) and low ASM re (men: 1.29, women: 0.69). As a result, sarcopenia was diagnosed in those with low GS re and low ASM re .
When the cut-off points that we identified were used, the proportion of individuals with sarcopenia was similar, regardless of height. With the FNIH criteria, 85.7% of sarcopenic older people (men: 89.5%, women: 80.0%) were in the lower quartile for height; with the AWGS criteria, 50% of sarcopenic older people (men: 46.0%, women: 54.5%) were in the lower quartile for height (Supplementary Table 1 ). To the best of our knowledge, the impact of short or tall height on a geriatric clinical outcome has not been reported to date. Therefore, our diagnostic criteria, which are less affected by height, are more suitable than the FNIH or AWGS diagnostic criteria for the diagnosis of sarcopenia in the Korean elderly population.
Because the FNIH project was conducted with Caucasians and African Americans, it was difficult to apply the FNIH criteria to older Koreans. In this study, we regarded the FNIH project as a framework, and modified the cut-off points for use in the Korean older population. Alternatively, the AWGS criteria were developed for the Asian population, and seemed applicable to Koreans. In this study, to compare the predictive validity of the new cut-off points with those of the FNIH and AWGS, logistic regression and ROC curve analyses were conducted, using the KFI as an outcome variable. Although there are many other frailty measures, we used KFI. Many frailty assessment methods require multiple clinical data, special techniques, or a prolonged time for measurement, and are unsuitable for use in primary care settings (10) . The Cardiovascular Health Study (CHS) frailty index is one of the most widely used tools for assessing frailty. However, the 5-item scale (weight loss, exhaustion, walking speed, physical activity, and grip strength) of the CHS frailty index has the shortcoming of overlapping of grip strength, which is included in the diagnostic criteria for sarcopenia. The KFI is a frailty assessment tool that was developed to meet the lifestyle, physique, and exercise capacity of Koreans. Moreover, it is a multi-dimensional index with proven validity for diagnosing frailty (10) . In ROC curve analysis, the predictive validities of the were similar; however, the prevalence was higher when the Korean sarcopenia criteria (Korean sarcopenia criteria, 38.7% of men and 30.0% of women; AWGS criteria, 11.7% of men and 9.0% of women) were applied. Despite the higher prevalence based on the Korean criteria, it was still possible to show that sarcopenia is associated with frailty. Our diagnostic criteria are able to detect more sarcopenic older people than are detected using the FNIH and AWGS criteria, without any reduction of predictive validity. Sarcopenia and physical frailty share many things in common; many researchers believe that sarcopenia is an effective physical frailty measurement (18) , or that the two represent different aspects of the same pathology (19) . However, based on the FNIH criteria, the prevalence of sarcopenia among communitydwelling elderly in the United States (17) and the United Kingdom (20) is 1%-2%, which is significantly lower than the 15% incidence of frailty assessed by the CHS frailty index among communitydwelling elderly in the United States (21). It is not yet clear which of the sarcopenia by FNIH criteria and the frailty using CHS frailty index would better reflect adverse outcomes in the elderly. However, because muscle strength and muscle mass are considered primary outcomes of sarcopenia (22) , and an appropriate diagnostic cut-off point is often used to determine treatment goals, criteria that are more generous than the current FNIH criteria are needed.
When the FNIH criteria derived from Caucasians are applied to Koreans, shorter people appear to be diagnosed more often with sarcopenia. We therefore suspect that there is a definite difference between races. The influence of height should not be unique to Koreans, but the lack of studies on other races or countries limit the results from being generalized. We believe diagnostic systems for sarcopenia should be established through future race-and/or countryspecific studies.
This study has several positive features. The participants were classified into three groups: not weak ("not weak" group), weak due to a low ASM ("sarcopenia" group), and weak from other causes ("other weak" group). As muscle strength is determined by neurological and muscular factors (23, 24) , it is reasonable to assume that weakness is caused by the same factors. However, sarcopenia is a state of weakness that is due to muscular causes, so the participants whose weakness is neurological in origin (i.e., being weak from other causes) had to be included in the "not weak" group in previous studies, regardless of the accuracy of the diagnostic criteria for sarcopenia. As shown in this study, the participants who were weak from other causes were also more likely to be frail; for this reason, it seems possible that the sarcopenia rates reported in previous studies are less significant than those found in the present study. Moreover, the gait speed (m/s) and GS re were used as explanatory continuous variables, whereas in the classification and regression tree (CART) analysis used by the FNIH project, the explanatory variables were slow gait speed (< 0.8 m/s) and weak grip (men: < 26 kg, women: < 16 kg) (2,3). Our method obtained more accurate results from a small sample size; furthermore, even if the cut-off points of gait speed and GS change in the future, the other variables can still be used.
This study also has certain limitations. As the participants were chosen from a single senior citizen retirement community, they probably do not represent the community-dwelling older Korean population as a whole. Most of the participants were healthy enough to exercise regularly in the retirement community, and were interested in their health and in lifelong learning. In addition, they were urbandwelling and middle-class, so their monthly income, education level, and health status was relatively higher than that of older Koreans in the general population. Although this study was conducted using a biased population, it is expected that the findings can be used until the results from a well-designed, larger study become available. In a pairwise comparison of ROC curves, the Korean sarcopenia criteria, FNIH, and AWGS criteria showed no significant differences between the groups for men, and the Korean sarcopenia criteria and AWGS criteria showed no significant differences between groups, but significant differences were evident regarding the FNIH in women (Korean sarcopenia criteria, AWGS ≠ FNIH).
Second, this study was conducted with a relatively small number of participants (916: 429 men and 487 women). Moreover, the number of frail individuals was relatively low (men: 7, women: 6) to assess the predictive validity of each criterion for sarcopenia. We combined pre-frail and frail status in one group in this study, which should be taken into account when interpreting the results. This combination of two groups could be a major limitation. To overcome these disadvantages, a well-designed, larger study is needed. Third, the calculation of the residual in a clinical situation is difficult. For the residual method to be used, an easier calculation method needs to be developed. We propose that further studies be conducted to assess not only the residual method but also previously used methods for the diagnosis of sarcopenia. Fourth, BIA rather than dual-energy X-ray absorptiometry (DXA) was used to measure ASM, even though DXA is considered the gold standard for such measurements in previous research. Although the lean mass measured by BIA showed good agreement with that measured using DXA in a study with a small sample size (25) , the correlation between the two has not been studied in a large population. Since the population in this study was recruited in a retirement community, where physical measurements were also obtained, and not in a hospital, it was necessary to use BIA, which is relatively more portable than DXA, to measure body composition; however, in this study, because the residual ASM was 1.013 kg ± 1.702 kg for men and 0.811 kg ± 1.340 kg for women, the authors determined an absence of critical problems regarding the interpretation of BIA-based measurement results. Additional research in which the usefulness of DXA and BIA for the assessment of ASM as a diagnostic indicator for sarcopenia are compared will be needed. Despite these limitations, this study has the advantage of being the first to establish diagnostic tools for sarcopenia that are dependent on the height of the subject, and also establishes new cut-off points.
Although South Korea has shown a rapid increase in the percentage of its older population, the knowledge base regarding sarcopenia and the way to address it is poor. As sarcopenia can induce frailty, and frailty can affect functional status as well as overall quality of life in older people, it is necessary to recognize and anticipate sarcopenia in this population. This study will promote further research on sarcopenia, and emphasizes the importance of assessing sarcopenia in clinical practice.
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